Explore small cap ideas before they hit the headlines.
Explore small cap ideas before they hit the headlines.
Always nice to see new hope for pphm. Now it is Trump to the rescue.
So they are not criminals ... but a scam .... is not far off. They are experts at transferring $$ from shareholders to their own pockets. Look at the salaries over the years, the totally outsized bod comp, the failure on all drug fronts (which is supposed to be their core business rights?), the 3rd RS just to stay listed ....
There is no reason to believe anyone offshore, or anywhere else, is buying up pphm. There is equally no reason to believe pphm will be any higher (in marketcap terms) after RS. What catalysts to a 700% price increase do you see?
Now warehousing by a potential acquirer id the reason for $.29 share price?
October 2013?
No it is a fact. There is a pending RS. It has been voted and approved. pphm will either increase by 333% (doubtful is kind) or there will be a RS.
You can say what you want but it is a lot easier to evaluate people and projects face to face.
You are presenting opions as facts:
4) Avid's backlog is bigger then its turn over, that must be included in the multiplication because it is SIGNED business with a fine if the orders would be cancelled.
No 1-2 times revenue is standard. Check comparable companies. And those multipliers are for well run profitable companies staffed for the mission of mfg. avid is bloated with pphm staff that negatively mpact a pure avid valuation. Do you really think pphm is mis-priced by 10x or more? For all this time now??
I would sell if they do an RS,
Yes, the tax loss is certainly not worth $100m. It would vary based on the acquirer and losses carried into an acquisition are complex but limited by regs. Also, you can't put a revenue multiplier value on Avid without deducting the cost of pphm overhead - what would amount to a liability/cost if you are basing the company value on Avid sales multiplier.
with such credibility behind Bavi as MSK/Jedd Wolchok confirming immune system stimulation and the need to further study in humans, NCCN trial participation, Birge, etc – why have they not been able to partner?
Or why have they been UNWILLING to partner
King and the BOD must have had other choices and opportunities and could have avoided this.
Funny how a hugely successful, as in the best on the planet, holds the ceo accountable for performance, but the pphm continues to overcomp for under-performance.
A CEO who takes responsibility. This is what King should have done after the botched PII
http://asia.nikkei.com/Business/Companies/CEO-of-Garuda-s-budget-unit-to-resign-over-drunk-pilot
Is that FY 2018 or calendar year?
Criminal
deplorable and shocking.
"he may never fulfill his potential, and that would be a criminal waste"
What is absurd is to think there will be no RS. They have less than 1 qtr. to get the share over $1. The fact that they had ATM sales at $.3x is pretty compelling clue that they have no event in the short-term to raise the shareprice 300-400%
Actually down 4% or .04
.4% would be less than 1/2 of a percent.
Quote:
AMI Sales Agreement - Subsequent to October 31, 2016 and through December 12, 2016, we sold 3,788,346 shares of common stock at market prices under the AMI Sales Agreement (Note 6) for aggregate gross proceeds of $1,174,000.
Quote:
Equity Distribution Agreement - Subsequent to October 31, 2016 and through December 12, 2016, we sold 1,587,909 shares of common stock at market prices under the Equity Distribution Agreement (Note 6) for aggregate gross proceeds of $496,000.
Also revenue generated where payment terms exceed gaap standards. If you give someone 120 day terms this revenue is deferred.
WHich is it pphm is the most read board or it is an unknown sleeper with great hidden value. PPHM was in Russell, it is followed by analyst, dart and his crowd aware - the problem isn't that no one knows about pphm. It si everyone KNOWS about pphm. They know about the failed trials, they know about the sleazy bod etc.
You think a 350% gain in next quarter?
this platform is being used, in part, by opposing biotechs that wish to discredit bavituximab.
Many are holding underwater shares hoping for miracle so they watch. You think the lurkers are hedge funds and bio competitors looking for hints of cancer cure? Why do people stop for train wrecks and car accidents?
and I say PS Targeting begins a new wave of fast FDA approvals
The stock cratered to below $.50 because of Sunrise failure. After the data it has now drifted here, trying to stay out of the $.20s How this is categorized as anything other than a huge disaster to shareholders is amazing.
vWhy would you even hint that someone would attempt to buy the company and take it private? Is this your plan? It won't work.
CEO Steve King doing a great job on the science side
Tax loss selling is upon us and is bound to render more fun times for longs in December.
So the LOUSY dollar isn't since LONG a PPHM/Avid issue anymore, it is a MARKET MANIPULATION problem because the company in its current state is worth more then 1$,
don't care about the control arms or sabotage case because i n the debate if it works it is Bavi's performance compared to TODAY's treatment (SOC) that is important, not compared to ABNORMAL control arms.
What I am thinking is that either PPHM has news that brings us above 1$ for 10 trading days (and CEO King thinks they may have such news) or they don't.
I even wonder if PPHM is still a US controlled company because the way the US allows trading/MM action/naked shorting etc these days it may well be that the nation wakes up some day realising that its crown jewels are owned by non-US entities that, under the greed of shorting and illegal naked sorting by others, grab the occasion to buy into companies that they believe have the goods.
PPHM is such company that without any doubt has the goods and of which the PPS is artificially low.
I think the PPS will in all cases be around 1$ and they might do a 1/7 to bring the stock in a price range where all brokers/II/Funds may buy it or advice it because it will be above 5$.
Today it is based on REAL VALUE/ASSETS (Labs), REAL measurable TAX deduction, measurable/growing and REPORTED 3rd party revenue (AVID) and a POTENTIAL of Bavituximab with WAY LESS RISK LEVELS then 2 or more years ago.
I would say they were forced to sell out due to fund RULES that said they had to if PPHM was dropped from R3K
Why would pphm settle for so little, given the huge damage if they had a case (sealed or not - which is common to protect proprietary info). Why would there be no indictments if this was a bp sponsored sabotage. In the end it did not matter as Sunrise failed proving the PII data was worthless.
What is known is pphm settled for likely less than their legal costs. No one faced any criminal charges. CRM is getting new business (funny many thought pphm would own or BK them). No claims ever made by pphm or any other party that a bp etc. was involved. In the end another mismanaged event by pphm.
Yes and Avid is worth 6-10x revenues. PPHM will soon have a test kit, the potential partners are in a bidding war but still short of pphm's astronomical value so no deal, a bla for the failed Sunrise trial is in the works, the bod deserve to be paid more than Fortune 500 bod members because they are sooo valuable to day to day operations, and ....I am from the government I am here to help you.
And Avid is worth > 5x revenues right? Can you name a similar company more than 2.5x revenues? And what will all this hiring do to cash flow needs.
1-2x sales there are comps for. > 5x sales? Who?
Sneak in there? How long has it been under $.50? The float turned how many times in that period? No trouble buying all the pphm you want.
Hmmm below 20,50,200 ma and negative macd. Why do you believe this?